ECML
Eagle Capital Management (Louisiana)’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06M | Buy |
126,401
+1,257
| +1% | +$30.5K | 1.35% | 23 |
|
|
2025
Q1 | $3.17M | Sell |
125,144
-680
| -0.5% | -$17.2K | 1.4% | 23 |
|
|
2024
Q4 | $3.34M | Sell |
125,824
-755
| -0.6% | -$20K | 1.35% | 23 |
|
|
2024
Q3 | $3.66M | Buy |
126,579
+425
| +0.3% | +$12.3K | 1.53% | 23 |
|
|
2024
Q2 | $3.53M | Buy |
126,154
+150
| +0.1% | +$4.2K | 1.56% | 23 |
|
|
2024
Q1 | $3.5M | Buy |
126,004
+1,056
| +0.8% | +$29.3K | 1.57% | 23 |
|
|
2023
Q4 | $3.6M | Buy |
+124,948
| New | +$3.6M | 1.75% | 19 |
|
|
2019
Q3 | – | Sell |
-84,677
| Closed | -$3.67M | – | 37 |
|
|
2019
Q2 | $3.67M | Buy |
84,677
+1,125
| +1% | +$48.7K | 1.99% | 20 |
|
|
2019
Q1 | $3.55M | Sell |
83,552
-455
| -0.5% | -$19.3K | 2.08% | 19 |
|
|
2018
Q4 | $3.67M | Sell |
84,007
-446
| -0.5% | -$19.5K | 2.76% | 12 |
|
|
2018
Q3 | $3.72M | Buy |
84,453
+1,173
| +1% | +$51.7K | 2.1% | 17 |
|
|
2018
Q2 | $3.02M | Buy |
83,280
+334
| +0.4% | +$12.1K | 1.9% | 24 |
|
|
2018
Q1 | $2.94M | Sell |
82,946
-778
| -0.9% | -$27.6K | 2.06% | 24 |
|
|
2017
Q4 | $3.03M | Sell |
83,724
-265
| -0.3% | -$9.6K | 1.63% | 25 |
|
|
2017
Q3 | $3M | Sell |
83,989
-276
| -0.3% | -$9.85K | 1.71% | 24 |
|
|
2017
Q2 | $2.83M | Sell |
84,265
-1,065
| -1% | -$35.8K | 1.68% | 27 |
|
|
2017
Q1 | $2.92M | Buy |
+85,330
| New | +$2.92M | 1.79% | 15 |
|